85 related articles for article (PubMed ID: 17695424)
1. Quality assurance of radiotherapy in a clinical trial for lymphoma: individual case review.
Shikama N; Oguchi M; Isobe K; Nakamura K; Tamaki Y; Hasegawa M; Kodaira T; Sasaki S; Kagami Y;
Anticancer Res; 2007; 27(4C):2621-5. PubMed ID: 17695424
[TBL] [Abstract][Full Text] [Related]
2. [Radiotherapy indications in non-Hodgkin lymphoma].
Quero L; Hennequin C; Brice P
Cancer Radiother; 2009 Oct; 13(6-7):471-8. PubMed ID: 19695926
[TBL] [Abstract][Full Text] [Related]
3. How can we determine the role of radiotherapy in the treatment of localized aggressive non-Hodgkin's lymphoma?
Gemici C; Salepci T
J Clin Oncol; 2007 Jul; 25(19):2857; author reply 2857-8. PubMed ID: 17602093
[No Abstract] [Full Text] [Related]
4. Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer: the individual case review.
Toita T; Oguchi M; Ohno T; Kato S; Niibe Y; Kodaira T; Kazumoto T; Kataoka M; Shikama N; Kenjo M; Teshima T; Kagami Y
Jpn J Clin Oncol; 2009 Dec; 39(12):813-9. PubMed ID: 19815538
[TBL] [Abstract][Full Text] [Related]
5. Treatment of localized lymphoma.
Hoecht S; Hinkelbein W
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948267
[No Abstract] [Full Text] [Related]
6. Treatment of localized lymphoma.
Adli M; Sevinc A; Kalender ME
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948268
[No Abstract] [Full Text] [Related]
7. Chemoradiotherapy for localized non-Hodgkin's lymphoma: lessons from old studies.
Basaran G; Basaran M; Onat H
J Clin Oncol; 2005 May; 23(13):3161-2; author reply 3162-3. PubMed ID: 15860887
[No Abstract] [Full Text] [Related]
8. To irradiate or not to irradiate--that is the question.
Trümper LH
Nat Clin Pract Oncol; 2005 Feb; 2(2):76-7. PubMed ID: 16264877
[No Abstract] [Full Text] [Related]
9. [Primary cervical epidural low-grade non-hodgkin's lymphoma: a case report and review of the literature].
Lahiani Ben Salah H; Daoud J
Cancer Radiother; 2008 Dec; 12(8):863-6. PubMed ID: 18565781
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review.
Matzinger O; Poortmans P; Giraud JY; Maingon P; Budiharto T; van den Bergh AC; Davis JB; Musat E; Ataman F; Huyskens DP; Gulyban A; Bolla M;
Radiother Oncol; 2009 Mar; 90(3):285-90. PubMed ID: 19038468
[TBL] [Abstract][Full Text] [Related]
11. Detailed review and analysis of complex radiotherapy clinical trial planning data: evaluation and initial experience with the SWAN software system.
Ebert MA; Haworth A; Kearvell R; Hooton B; Coleman R; Spry N; Bydder S; Joseph D
Radiother Oncol; 2008 Feb; 86(2):200-10. PubMed ID: 18077034
[TBL] [Abstract][Full Text] [Related]
12. Process control analysis of IMRT QA: implications for clinical trials.
Pawlicki T; Yoo S; Court LE; McMillan SK; Rice RK; Russell JD; Pacyniak JM; Woo MK; Basran PS; Boyer AL; Bonilla C
Phys Med Biol; 2008 Sep; 53(18):5193-205. PubMed ID: 18728311
[TBL] [Abstract][Full Text] [Related]
13. Results of treatment of 112 cases of primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
[TBL] [Abstract][Full Text] [Related]
14. Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer.
Chung HT; Lee B; Park E; Lu JJ; Xia P
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1167-74. PubMed ID: 18234440
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
[TBL] [Abstract][Full Text] [Related]
16. Role of radiation therapy in localized aggressive lymphoma.
Ng AK; Mauch PM
J Clin Oncol; 2007 Mar; 25(7):757-9. PubMed ID: 17228015
[No Abstract] [Full Text] [Related]
17. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
Arranz R; Conde E; Grande C; Mateos MV; Gandarillas M; Albo C; Lahuerta JJ; Fernández-Rañada JM; Hernández MT; Alonso N; García Vela JA; Garzón S; Rodríguez J; Caballero D;
Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400
[TBL] [Abstract][Full Text] [Related]
18. Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy.
Wills L; Maggs R; Lewis G; Jones G; Nixon L; Staffurth J; Crosby T;
Radiat Oncol; 2017 Nov; 12(1):179. PubMed ID: 29141663
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances and the treatment strategies of AIDS-related malignant lymphoma].
Okada S
Rinsho Ketsueki; 2008 Oct; 49(10):1490-8. PubMed ID: 18833933
[No Abstract] [Full Text] [Related]
20. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]